Figure 3. Concentrations of caffeine in matched plasma and CSF samples of LRRK2 Cohort Consortium (LCC) participants.
Concentrations of caffeine in matched plasma (A) and CSF (B) samples of LCC participants by LRRK2 and Parkinson disease (PD) status, adjusted for age, sex, and study site cohort. UC = unaffected controls.